MRPL51 and Alzheimer disease: To further demonstrate that changes in the transcriptomic profile can serve as indicators of AD onset and progression, Huseby et al. (2022) utilised a panel of transcripts from genes including MRPL51, NDUFA1, and NDUFS5 to distinguish AD samples from healthy controls, achieving an AUC of around 80%.